cymedica
-
Extremities
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
SCOTTSDALE, Ariz., June 16, 2020 CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that…
Read More » -
Hospitals
CyMedica Orthopedics® announces FDA clearance for e-vive™, the first app-driven muscle activation therapy and patient engagement solution for pre and post-operative knee surgery rehabilitation
SCOTTSDALE, Ariz., Jan. 17, 2017 /PRNewswire/ — CyMedica Orthopedics®, developer and manufacturer of innovative muscle rehabilitation systems announced that it received U.S.…
Read More » -
Hospitals
CyMedica Orthopedics® Receives CE Mark For The CyMedica QB1™ Muscle Activation System
SCOTTSDALE, Ariz., Aug. 11, 2015 /PRNewswire/ — CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for…
Read More » -
Financial
CyMedica Orthopedics raises $6 million
Scottsdale medical device company CyMedica Orthopedics completed a $6 million raise, or so says a recent regulatory filing. The highly hush-hush…
Read More »